Please login to the form below

Not currently logged in

Excellence in Continuous Development: Education Services for Global or Emerging Markets

Sponsored by

Back to Results


Changing Diabetes ® in Children

by Novo Nordisk

Summary of work

An estimated 497,000 children have type 1 diabetes worldwide. About half live in low-income countries, often without the necessary treatment. These children have high mortality rates, and in some sub-Saharan African countries life-expectancy is less than one year after diagnosis.

As a response, Novo Nordisk, a global healthcare company with leadership in diabetes care, established the Changing Diabetes® in Children programme in 2009. Working in partnership with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF), Novo Nordisk aims to build long-term solutions for improving availability, accessibility, affordability and quality of care for children with type 1 diabetes.

The programme establishes clinics where children are diagnosed and receive specialised care. It also trains healthcare professionals, and educates patients and families about caring for a child with diabetes. To overcome financial hurdles, it entails free provision of insulin and blood glucose measuring equipment for the children.

In 2013-2014, 3,489 new children were enrolled, 33 new clinics established and 2,918 new healthcare professionals trained. The programme runs in nine countries.

Judges' comments

Novo Nordisk has produced a really tremendous programme. Local engagement was excellent; the strategy of collaboration operated at the highest level and brought in the rest of the cross functional team. Throughout they showed clear sustainability and operational learnings that enabled them to continuously improve. Quite simply, the judges loved every single element.


European SpA Imaging Working Group programme - by AbbVie
with support from Sciterion

#IGiveA campaign - by RB (Reckitt Benckiser)
with support from Tonic Life Communications

Rethinking Hepatitis - by World Hepatitis Alliance
with support from Ketchum

Key dates

Entry deadline 29 August 2019
Extended entry deadline 5 September 2019*
*additional fee applies
Judging day 26 September 2019
Company/Team Interviews 9 October 2019
PMEA Event 27 November 2019